Filter Results
:
(2,406)
Show Results For
-
All HBS Web
(2,406)
- People (6)
- News (560)
- Research (1,696)
- Events (8)
- Multimedia (14)
- Faculty Publications (1,329)
Show Results For
-
All HBS Web
(2,406)
- People (6)
- News (560)
- Research (1,696)
- Events (8)
- Multimedia (14)
- Faculty Publications (1,329)
- Portrait Project
Emma Beck
shaped my fundamental belief about people – if everyone could choose, they’d wake up and choose to be their best. But not everyone gets that choice, often because of their mental health. Propelled by this belief, I’m building a company...
View Details
- 25 Jul 2023
- Research & Ideas
Could a Business Model Help Big Pharma Save Lives and Profit?
With Hepatitis C running rampant in Egypt in 2012, Clifford Samuel, then of California-based Gilead Sciences, convened a series of urgent meetings with Egyptian government officials, doctors, and patients....
View Details
- 22 Feb 2017
- HBS Seminar
Juliet Schor, Boston College
- 09 Feb 2024
- HBS Case
Slim Chance: Drugs Will Reshape the Weight Loss Industry, But Habit Change Might Be Elusive
Year after year, millions of people make a new year’s resolution to lose weight. But because success traditionally depends on making major lifestyle changes, like eating healthier and exercising more, many people fall short View Details
- 14 Jul 2023
- Blog Post
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows
Patrick will focus on product and research development at Raia Health with the goal of using AI-driven supported care to reduce patient-related symptom load and improve treatment completion for anti-cancer...
View Details
- Portrait Project
Genevieve Sheehan
every day — may give me a safety net of sorts. But it also keeps me from owning my decisions. I will not be prisoner to what I think other people think I should do. Instead, I'll put myself on the line. I'll...
View Details
- 2019
- Working Paper
Identification Using Border Approaches and IVs
By: Xing Li, Wesley R. Hartmann and Tomomichi Amano
We document that recent quasi-experimental strategies for identifying advertising effects can be derived from a model in which ad decisions are made at a more aggregate level than conversion is measured. Next, we show that the identifying variation in one of these...
View Details
Li, Xing, Wesley R. Hartmann, and Tomomichi Amano. "Identification Using Border Approaches and IVs." Working Paper, June 2019.
- 10 Nov 2014
- Working Paper Summaries
Crony Capitalism, American Style: What Are We Talking About Here?
Keywords:
by Malcolm S. Salter
- 22 Feb 2024
- News
Combat-Tested Cancer Coaching
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When Kathy Giusti (MBA 1985) was diagnosed with multiple myeloma in 1996, she was overwhelmed. It was the pre-Internet era, with limited available information, but...
View Details
- 30 Jul 2007
- Research & Ideas
Repugnant Markets and How They Get That Way
afterward." Some of my surgical colleagues are worried. Even if using organs of executed prisoners is repugnant, it would certainly be even more repugnant to execute View Details
Keywords:
by Martha Lagace
- 15 Jul 2013
- Research & Ideas
Five Imperatives for Improving Health Care
Innovation in health care treatment seems to far outpace innovation in health care business management. Just ask President Obama—two weeks ago he delayed enactment of a key provision View Details
- 22 Mar 2021
- Research & Ideas
How to Learn from the Big Mistake You Almost Make
member noticed this, and the patient’s treatment was postponed until they received clearance. Almost happened. The pacemaker status was not checked. The patient had a pacemaker and received radiation, but, by chance, the patient did not...
View Details
- Web
Organize Care Around Medical Conditions - Institute For Strategy And Competitiveness
with clear timelines and measures of progress. One of the most important aspects of an effective IPU are regular multidisciplinary case reviews View Details
- Web
HBS Health Care Initiative - Blog: Health Supplement
diseases have an approved therapy. It’s a dilemma that is historically overlooked, largely because it’s hard to make a profit from a treatment that affects so few people. How do we empower patients with rare diseases when a lack View Details
- Web
Program Policies - HBS Online
following are general documentation guidelines for your reference: Documentation presents a clear assessment of the disability or condition by a licensed provider with firsthand knowledge and relevant credentials. Documentation is signed...
View Details
- 30 Nov 2015
- Research & Ideas
Donors Are Turned Off by Overhead Costs. Here’s What Charities Can Do
Many of us would prefer to see our philanthropic donations go directly to an organization’s core mission, rather than to administrative expenses. If we give money to Save the Children, for instance, we hope the cash goes directly to those...
View Details
Keywords:
by Carmen Nobel
- 26 Mar 2013
- Working Paper Summaries
How Elastic Are Preferences for Redistribution? Evidence from Randomized Survey Experiments
- Research Summary
Selling China: Foreign Direct Investment During the Reform Era
The aim of the book is to illustrate the dynamics of foreign direct investment (FDI) in China in the 1990s. The topic is important both because China is the world's second largest recipient of FDI and because there are substantial misconceptions about the drivers of...
View Details
- 12 Sep 2023
- Cold Call Podcast
Can Remote Surgeries Digitally Transform Operating Rooms?
- 2014
- Working Paper
Better Deals Through Level II Strategies: Advance Your Interests by Helping to Solve Their Internal Problems
Many negotiators have constituencies that must formally or informally approve an agreement. Traditionally, it is the responsibility of each negotiator to manage the internal conflicts and constituencies on his or her own side. Far less familiar are the many valuable...
View Details
Sebenius, James K. "Better Deals Through Level II Strategies: Advance Your Interests by Helping to Solve Their Internal Problems." Harvard Business School Working Paper, No. 14-091, March 2014.